Unilife to Present at the Barclays Global Healthcare Conference on March 13th

PR Newswire

YORK, Pa., March 5, 2014 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that its Chairman and CEO, Alan Shortall, will present at the Barclays Global Healthcare Conference in Miami at 09:00 a.m. ET on Thursday, March 13, 2014.

The conference presentation will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. An archive of the event will also be available for those unable to listen live.

About Unilife Corporation

Unilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife's broad portfolio of proprietary technologies includes prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and novel systems. Each of these innovative and highly differentiated platforms can be customized to address specific customer, drug and patient requirements. Unilife's global headquarters and state-of-the-art manufacturing facilities are located in York, PA. For more information, please visit www.unilife.com or download the Unilife IRapp on your iPhone, iPad or Android device.

General: UNIS-G

Investor Contacts (US):                    

Analyst Enquiries        

Investor Contacts (Australia)

Todd Fromer / Garth Russell             

Lynn Pieper                 

Jeff Carter

KCSA Strategic Communications        

Westwicke Partners     

Unilife Corporation

P: + 1 212-896-1215 / 212-896-1250        

P: + 1 415-202-5678    

P: + 61 2 8346 6500

 

Rates

View Comments (0)